去除主要孔蛋白的脑膜炎球菌外膜囊泡疫苗增强对异源B群脑膜炎奈瑟菌菌株的反应性
本研究从B群脑膜炎奈瑟菌中制备缺失主要外膜蛋白(PorA、PorB、RmpM)的去垢剂提取脱毒外膜囊泡(dOMV)疫苗,免疫兔和小鼠后检测针对五株MenB菌株的抗体应答。野生型dOMV疫苗诱导针对PorA、PorB、RmpM和脂寡糖(LOS)的抗体,但对异源菌株杀菌活性有限;OMP缺失dOMV疫苗诱导广泛交叉反应杀菌抗体,其中PorA/PorB双缺失dOMV诱导的交叉反应性最强。增强的异源菌株杀伤与免疫印迹中独特蛋白条带结合相关,提示野生型疫苗中表达不足的抗原免疫原性改善。
要点
- 野生型dOMV疫苗对异源MenB菌株杀菌活性有限。
- OMP缺失dOMV疫苗诱导广泛交叉反应杀菌抗体。
- PorA/PorB双缺失dOMV诱导的交叉反应性最强。
核心结论
- 去除主要外膜蛋白(包括PorA、PorB和RmpM)的dOMV疫苗可诱导广泛交叉反应杀菌抗体,其中PorA/PorB双缺失dOMV诱导的交叉反应性最强。
研究设计与样本
- 本研究分离缺失主要外膜蛋白(包括PorA、PorB和RmpM)的dOMV疫苗,免疫兔和小鼠,采集血清检测针对五株MenB菌株的抗体应答。
主要发现
- 野生型dOMV免疫诱导针对PorA、PorB、RmpM和LOS的抗体,但对异源菌株杀菌活性有限。
- OMP缺失dOMV疫苗诱导广泛交叉反应杀菌抗体,PorA/PorB双缺失dOMV诱导的抗体交叉反应性最强。
- 增强的异源菌株杀伤与免疫印迹中独特蛋白条带结合相关,提示野生型疫苗中表达不足的抗原免疫原性改善。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Detergent-extracted detoxified outer membrane vesicle (dOMV) vaccines are effective at preventing invasive serogroup B meningococcal (MenB) disease caused by the homologous Neisseria meningitidis strain from which they are produced, but offer limited protection from heterologous strains. Differences in vaccine efficacy are partially due to strain-specific variations in the antigenic sequence types and expression levels of outer membrane proteins (OMPs), including the immunodominant OMP PorA. In this study, dOMV vaccines deficient in major OMPs, including PorA, PorB, and RmpM were isolated and used to immunize rabbits and mice. Serum samples were obtained from each animal and tested for antibody responses against five MenB strains. Immunization with wild type dOMVs elicited antibodies to major antigens including PorA, PorB, RmpM, and lipooligosaccharide (LOS), and demonstrated limited bactericidal activity against heterologous strains. In contrast, OMP-deficient dOMV vaccines elicited broadly cross-reactive bactericidal antibodies, with PorA/PorB-dual deficient dOMVs inducing antibodies exhibiting the greatest cross-reactivity. Enhanced killing of heterologous strains correlated with binding to unique protein bands in immunoblots, suggestive of improved immunogenicity of antigens under-represented in the wild type vaccine.
引用
- Matthias KA, Reveille A, Connolly KL, et al. Deletion of major porins from meningococcal outer membrane vesicle vaccines enhances reactivity against heterologous serogroup B Neisseria meningitidis strains. Vaccine. 2020. PMID: 32037226. doi:10.1016/j.vaccine.2020.01.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。